Cargando…

Dihydroartemisinin Alleviates Imiquimod-Induced Psoriasis-like Skin Lesion in Mice Involving Modulation of IL-23/Th17 Axis

Background: Psoriasis is a T help 17 (Th17) cell-mediated chronic inflammatory skin disease. Recent studies have shown that dihydroartemisinin (DHA) can significantly reduce experimental autoimmune encephalomyelitis and rheumatoid arthritis by regulating Th17 cells. Objective: To verify whether DHA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jiang-Min, Jin, Quan-Xin, Fujimoto, Manabu, Li, Fang-Fang, Jin, Lin-Bo, Yu, Ran, Yan, Guang-Hai, Zhu, Lian-Hua, Meng, Fan-Ping, Zhang, Qing-Gao, Jin, Gui-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415163/ https://www.ncbi.nlm.nih.gov/pubmed/34483908 http://dx.doi.org/10.3389/fphar.2021.704481

Ejemplares similares

Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis
por: QIN, SI, et al.
Publicado: (2014)

Trichinella pseudospiralis-secreted 53 kDa protein ameliorates imiquimod-induced psoriasis by inhibiting the IL-23/IL-17 axis in mice
por: Khueangchiangkhwang, Sukhonthip, et al.
Publicado: (2022)

The role of IL‐23 and the IL‐23/T(H)17 immune axis in the pathogenesis and treatment of psoriasis
por: Girolomoni, G., et al.
Publicado: (2017)

Forsythoside A Alleviates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Regulating Th17 Cells and IL-17A Expression
por: Lin, Hsuan, et al.
Publicado: (2022)

Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases
por: Yu, Ran, et al.
Publicado: (2021)

IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis
por: Hou, Yuzhu, et al.
Publicado: (2018)

Shikonin inhibits CEBPD downregulation in IL-17-treated HaCaT cells and in an imiquimod-induced psoriasis model
por: Lan, Xiao-Ou, et al.
Publicado: (2020)

Immunohistochemical Comparison of IL-36 and the IL-23/Th17 Axis of Generalized Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis
por: Song, Hyo Sang, et al.
Publicado: (2016)

Ustekinumab in Psoriasis Immunopathology with Emphasis on the Th17-IL23 Axis: A Primer
por: Quatresooz, Pascale, et al.
Publicado: (2012)

Coptisine Alleviates Imiquimod-Induced Psoriasis-like Skin Lesions and Anxiety-like Behavior in Mice
por: Nguyen, Ly Thi Huong, et al.
Publicado: (2022)

Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies
por: Bugaut, Hélène, et al.
Publicado: (2021)

Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
por: Boutet, Marie-Astrid, et al.
Publicado: (2018)

SHP2 allosteric inhibitor TK-453 alleviates psoriasis-like skin inflammation in mice via inhibition of IL-23/Th17 axis
por: Wang, Meijing, et al.
Publicado: (2022)

Curcumin alleviates imiquimod‐induced psoriasis‐like inflammation and regulates gut microbiota of mice
por: Cai, Zhenguo, et al.
Publicado: (2023)

Alleviation of imiquimod-induced psoriasis-like symptoms in Rorα-deficient mouse skin
por: Park, Koog Chan, et al.
Publicado: (2023)

An Analysis of IL-10, IL-17A, IL-17RA, IL-23A and IL-23R Expression and Their Correlation with Clinical Course in Patients with Psoriasis
por: Kutwin, Magdalena, et al.
Publicado: (2021)

IOX1 impedes host inflammation in imiquimod-triggered psoriasis
por: Shin, Joo Eun, et al.
Publicado: (2021)

Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A–Producing γδ T Cells
por: Zhang, Song, et al.
Publicado: (2021)

Compositional Alteration of Gut Microbiota in Psoriasis Treated with IL-23 and IL-17 Inhibitors
por: Huang, Yu-Huei, et al.
Publicado: (2023)

Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients
por: Yen, Ling-Jung, et al.
Publicado: (2022)

Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist
por: Li, Qingran, et al.
Publicado: (2021)

Topical Application of Mesenchymal Stem Cell Exosomes Alleviates the Imiquimod Induced Psoriasis-Like Inflammation
por: Zhang, Bin, et al.
Publicado: (2021)

Effects of Cyclosporine on Palmoplantar Pustulosis and Serum Expression of IL-17, IL-23, and TNF-α
por: Jin, Xian-Hua, et al.
Publicado: (2019)

The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis
por: Schön, Michael P., et al.
Publicado: (2018)

Dihydroartemisinin alleviates morphine-induced neuroinflammation in BV-2 cells
por: Guan, Sen, et al.
Publicado: (2021)

The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis
por: Vecellio, Matteo, et al.
Publicado: (2021)

Rapamycin Alleviates 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Aggravated Dermatitis in Mice with Imiquimod-Induced Psoriasis-Like Dermatitis by Inducing Autophagy
por: Kim, Hye Ran, et al.
Publicado: (2021)

Extracts from Seseli mairei Wolff attenuate imiquimod-induced psoriasis-like inflammation by inhibiting Th17 cells
por: Wang, Mengmeng, et al.
Publicado: (2023)

Indoleamine 2,3-Dioxygenase 2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation
por: Fujii, Kento, et al.
Publicado: (2020)

Commensal-dependent expression of IL-25 regulates the IL-23–IL-17 axis in the intestine
por: Zaph, Colby, et al.
Publicado: (2008)

Potential Role of Probiotics in Ameliorating Psoriasis by Modulating Gut Microbiota in Imiquimod-Induced Psoriasis-Like Mice
por: Lu, Wenwei, et al.
Publicado: (2021)

IL‐23/IL‐17 axis and soluble receptors isoforms sIL‐23R and sIL‐17RA in patients with rheumatoid arthritis‐presenting periodontitis
por: Rodríguez‐Montaño, Ruth, et al.
Publicado: (2021)

Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis
por: Ceribelli, Angela, et al.
Publicado: (2021)

Curcumin Inhibits Imiquimod-Induced Psoriasis-Like Inflammation by Inhibiting IL-1beta and IL-6 Production in Mice
por: Sun, Jun, et al.
Publicado: (2013)

Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis
por: Miyagawa, Hanae, et al.
Publicado: (2021)

Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases
por: Bunte, Kübra, et al.
Publicado: (2019)

The Th17/IL-23 Axis and Natural Immunity in Psoriatic Arthritis
por: Maeda, Shinji, et al.
Publicado: (2012)

Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis
por: Xiao, Chun-Ying, et al.
Publicado: (2020)

Impact of Obesity on the IL-6 Immune Marker and Th17 Immune Cells in C57BL/6 Mice Models with Imiquimod-Induced Psoriasis
por: Park, So Hee, et al.
Publicado: (2023)

The role of IL-23 in the immunopathogenesis of psoriasis
por: Meglio, Paola Di, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_be5ggjr9hmfe8fuq22ohprg4kb